Sign in

Parag Bawaskar

@paragbawaskar.bsky.social
626 followers 182 following 33 posts

Cardiologist, Post Doctoral Research Associate, Cardiovascular Division, University of Minnesota Medical School.

PostsRepliesMedia
Reposted by Parag Bawaskar
TCTMD @tctmd.bsky.social · 29/04/2026
Autopsy Studies Turn Sudden Cardiac Death Wisdom on Its Head
tctmd.com
Autopsy Studies Turn Sudden Cardiac Death Wisdom on Its Head
Autopsy Studies Turn Sudden Cardiac Death Wisdom on Its Head cmacahilig@crf.org Wed, 04/29/2026 - 16:47 Michael O'Riordan New data hint that MI is not the main driver of SCD and that many patients have undetected cardiac disease.
022
Reposted by Parag Bawaskar
TCTMD @tctmd.bsky.social · 23/04/2026
Eugene Braunwald, ‘Icon’ of Modern Cardiology, Dies at 96
tctmd.com
Eugene Braunwald, ‘Icon’ of Modern Cardiology, Dies at 96
Eugene Braunwald, ‘Icon’ of Modern Cardiology, Dies at 96 hdellabella@crf.org Thu, 04/23/2026 - 17:08 Yael L. Maxwell With a career in medicine spanning eight decades, Braunwald will be remembered for his impact on every corner of the field.
025
Reposted by Parag Bawaskar
Duke Clinical Research Institute @dcrinews.bsky.social · 29/03/2026
Misinformation reaches 1 billion people in seconds. Debunking it takes work. At #ACC26, former FDA Commissioner and DCRI founder, Rob Califf encouraged clinicians to engage in new media — or risk losing the battle for public trust without ever competing. #HealthPolicy #CardioSky
021
Parag Bawaskar @paragbawaskar.bsky.social · 01/04/2026
🧵 Are OCT and CMR really "complementary" in MINOCA? Or are they telling us conflicting stories? Reynolds et al (Circulation 2026) combined both modalities in 284 MINOCA patients. The results raise more questions than answers. 📄 www.ahajournals.org/doi/abs/10.1... 1/7
ahajournals.org
American Heart Association Journals
222
Parag Bawaskar @paragbawaskar.bsky.social · 28/02/2026
APERITIF tested low-dose rivaroxaban+ DAPT vs DAPT alone to prevent LV thrombus after anterior STEMI. Primary endpoint: LVT on contrast-enhanced CMR at 1 month. Result: no significant difference (13.7% vs 16.6%, p=.34).But there's a screening problem worth discussing. jamanetwork.com/journals/jam...
jamanetwork.com
Low-Dose Rivaroxaban to Prevent Left Ventricular Thrombosis After Anterior Myocardial Infarction
This multicenter randomized clinical trial conducted in France determines whether the addition of low-dose rivaroxaban to dual antiplatelet therapy reduces the incidence of left ventricular thrombus a...
231
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 24/05/2025
academic.oup.com/eurheartj/ad... @escardio.bsky.social #Cardiosky #WhyCMR #Epeeps #Medsky Please DM me if you would like a full-text PDF of the paper!
4106
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 11/06/2025
Thank you, @toddneale.bsky.social, for your excellent reporting on our EHJ paper! @tctmd.bsky.social @escardio.bsky.social @paragbawaskar.bsky.social
361
Reposted by Parag Bawaskar
Martin Ugander @mugander.bsky.social · 23/03/2025
Query sarcoid, normal #WhyCMR, so then should we do FDG-PET? Not much benefit.
052
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 21/03/2025
Read our accompanying editorial for our thoughts on the important paper – academic.oup.com/ehjcimaging/... @paragbawaskar.bsky.social #CardioSky #MedSky #Sarcoidosis
academic.oup.com
Cardiac FDG-PET imaging in patients with suspected cardiac sarcoidosis and no late gadolinium enhancement on cardiovascular magnetic resonance imaging: the emperor has no clothes!
This editorial refers to ‘The Role of FDG PET/CT in Assessing Cardiac Sarcoidosis with No High-Risk Cardiac Features and Normal CMR’, by F. Shuduyeva et al
033
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 21/03/2025
In patients with suspected cardiac sarcoidosis, cardiac FDG-PET is recommended after a normal CMR if there is a high clinical suspicion. What are the data supporting this recommendation? #CardioSky #MedSky #Sarcoidosis
2106
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 23/01/2025
This paper reports the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy in 5 patients. heart.bmj.com/content/earl... #CardioSky #MedSky
heart.bmj.com
Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre case-control study
Background Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting desmo...
153
Reposted by Parag Bawaskar
Pradeep Natarajan @pnatarajanmd.bsky.social · 23/11/2024
In honor of Dr. Braunwald’s 95th birthday. The number of areas he has touched in cardiology is staggering, and number of cardiovascular professionals is unquantifiable. @harvardmed.bsky.social
03610
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 17/11/2024
Amazing achievement by rising star and post-doc in my lab @paragbawaskar.bsky.social, winner of the prestigious 2024 Melvin Judkins Early Career Investigator Award at #AHA24!! Congratulations!!! @ahascience.bsky.social
1154
Reposted by Parag Bawaskar
Lars Mølgaard Saxhaug @load-dependent.eurosky.social · 13/11/2024
It’s great that journals are coming over here, but what I have really missed after my departure from Twitter 2 years ago is this, the authors themselves presenting their works and discussing it with peers. #cardiosky #medsky #emimcc
2317
Reposted by Parag Bawaskar
Chetan Shenoy @cshenoy.bsky.social · 12/11/2024
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years. We were puzzled by the finding… #CardioSky www.ahajournals.org/doi/10.1161/...
Figure 2 from the paper. Incidence of embolism in left ventricular (LV) thrombus patients compared with matched non-LV thrombus patients. Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic end point in the LV thrombus (in red) and in the matched non-LV thrombus (in blue) groups. Note the significant difference in the cumulative incidence of embolic events between the 2 groups.
32416
Parag Bawaskar @paragbawaskar.bsky.social · 11/11/2023
Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”? You might be interested in our paper now out in Circulation #simultaneouspublication #AHA23 #cardiosky #Medsky #WhyCMR
2115